Anavex Life Sciences (AVXL) Financials: Revenue & Earnings

AVXL price $1.27 -0.04 -2.67%

Ticker
AVXL
Price
$1.27
Change
-0.04 -2.67%
Market cap ?
$118.19M
P/E ?
-4.90
Forward P/E ?
0.56
Dividend yield ?
0.00%
Beta ?
1.17
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
70
Value
59
Quality
52
Growth
100

Stocklytics score rationale: value 59, quality 52, growth 100.

Financials

2016201720182019202020212022202320242025
0000000000

Operating as a clinical-stage biopharmaceutical entity, Anavex Life Sciences Corp. specializes in developing therapeutic drug candidates for various central nervous system (CNS) conditions. Its leading compound, ANAVEX 2-73, is currently in advanced development, undergoing Phase III clinical evaluation for both Alzheimer's disease and pediatric Rett syndrome. This same drug is also in Phase II trials for Parkinson's…

Fair value

AVXL fair value $89.12. Price $1.27. Price is 99% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare AVXL

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-24—-0.11——
2026-08-28-0.03-0.08——
2026-08-250.08-0.08——
2026-02-09-0.06-0.10——
2025-11-25-0.11-0.13—111.56M
2025-08-12-0.16-0.13—71.73M
2025-05-13-0.13-0.16—45.53M
2025-02-12-0.14-0.17——
2024-12-23-0.14-0.16—45.92M
2024-08-06-0.14-0.16——
2024-05-09-0.13-0.11——
2024-02-07-0.11-0.14——
2023-11-27-0.12-0.15——
2023-08-08-0.14-0.17——
2023-05-09-0.17-0.19——
2023-02-07-0.17-0.19——
2022-11-28-0.18-0.16——
2022-08-09-0.16-0.15——
2022-05-10-0.14-0.17——
2022-02-09-0.14-0.15——
2021-11-24-0.15-0.15——
2021-08-12-0.14-0.13——
2021-05-13-0.12-0.14——
2021-02-11-0.12-0.11——
2020-12-28-0.10-0.13——
2020-08-06-0.11-0.14——
2020-05-07-0.12-0.15——
2020-02-06-0.12-0.14——
2019-12-16-0.07-0.15——
2019-08-07-0.14-0.17——
2019-05-08-0.13-0.14——
2019-02-07-0.16-0.13——
2018-12-12-0.13-0.11——
2018-08-09-0.06-0.10——
2018-05-10-0.11-0.10——
2018-02-07-0.09———
2017-12-11-0.12-0.10——
2017-08-07-0.09-0.09——
2017-05-10-0.09-0.09——
2017-02-07-0.08———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-24Senderowicz AdrianOther0——
2026-09-24Patel GautamOther0——
2026-09-24Boenisch SandraBuy25.00K$8.57214.25K
2026-09-24Boenisch SandraBuy25.00K$5.36134.00K
2026-09-24Boenisch SandraBuy25.00K$8.58214.50K
2026-09-24Boenisch SandraBuy20.00K$10.09201.80K
2026-05-04Kellmeyer TerrieOther50.00K$8.58429.00K
2026-05-04Kellmeyer TerrieOther46.67K$7.21336.48K
2026-05-04Kellmeyer TerrieOther7.50K$5.3640.20K
2026-02-23Paeger AxelOther0——
2026-01-06MISSLING CHRISTOPHER UBuy125.00K$8.581.07M
2026-01-06Boenisch SandraBuy12.50K$8.58107.25K
2025-10-02Boenisch SandraBuy12.50K$5.3667.00K
2025-10-02MISSLING CHRISTOPHER UBuy125.00K$5.36670.00K
2025-09-11MISSLING CHRISTOPHER UBuy187.50K$5.04945.00K
2025-09-11MISSLING CHRISTOPHER USell145.05K$9.581.39M
2025-09-11MISSLING CHRISTOPHER USell187.50K$5.04945.00K
2025-08-20Boenisch SandraBuy12.50K$8.58107.25K
2025-08-20MISSLING CHRISTOPHER UBuy125.00K$8.581.07M
2025-06-05Thomas SteffenBuy50.00K$1.7688.00K
2025-06-05Thomas SteffenSell11.35K$7.7587.95K
2025-06-05Thomas SteffenSell50.00K$1.7688.00K
2025-04-28Boenisch SandraBuy12.50K$8.57107.12K
2025-04-28MISSLING CHRISTOPHER UBuy125.00K$8.571.07M
2025-03-31Donhauser Peter D.O.Buy50.00K$8.58429.00K
2025-03-31Ma JiongBuy50.00K$8.58429.00K
2025-03-31Skarpelos AthanasiosBuy50.00K$8.58429.00K
2025-03-31Thomas SteffenBuy50.00K$8.58429.00K
2025-03-31Velden Claus VanderBuy50.00K$8.58429.00K
2025-03-24MISSLING CHRISTOPHER UBuy500.00K$0.92460.00K
2025-03-24MISSLING CHRISTOPHER USell282.50K$9.632.72M
2025-03-24MISSLING CHRISTOPHER USell500.00K$0.92460.00K
2025-01-15MISSLING CHRISTOPHER UBuy166.67K$7.541.26M
2025-01-15MISSLING CHRISTOPHER UBuy125.00K$8.571.07M
2025-01-15Boenisch SandraBuy12.50K$8.57107.12K
2024-12-19Boenisch SandraBuy12.50K$5.3667.00K
2024-12-19MISSLING CHRISTOPHER UBuy125.00K$5.36670.00K
2024-11-19MISSLING CHRISTOPHER UBuy125.00K$10.091.26M
2024-11-19Boenisch SandraBuy10.00K$10.09100.90K
2024-06-14Donhauser Peter D.O.Buy2.83K$3.6410.32K
2024-05-15Thomas SteffenBuy5.00K$4.5222.60K
2024-03-28MISSLING CHRISTOPHER UBuy73.38K$1.3296.86K
2024-03-28MISSLING CHRISTOPHER USell73.38K$5.11374.97K
2024-03-28MISSLING CHRISTOPHER USell73.38K$1.3296.86K
2024-02-20Donhauser Peter D.O.Buy50.00K$5.36268.00K
2024-02-20Thomas SteffenBuy50.00K$5.36268.00K
2024-02-20Velden Claus VanderBuy50.00K$5.36268.00K
2024-02-20Ma JiongBuy50.00K$5.36268.00K
2024-02-20Skarpelos AthanasiosBuy50.00K$5.36268.00K
2024-01-02MISSLING CHRISTOPHER USell125.00K$10.091.26M
2024-01-02Boenisch SandraBuy10.00K$10.09100.90K
2023-06-29MISSLING CHRISTOPHER UBuy232.00K$1.60371.20K
2023-06-29MISSLING CHRISTOPHER USell232.00K$1.60371.20K
2023-06-28MISSLING CHRISTOPHER UBuy268.00K$1.60428.80K
2023-06-28MISSLING CHRISTOPHER USell268.00K$7.982.14M
2023-06-28MISSLING CHRISTOPHER USell268.00K$1.60428.80K
2023-03-31Ma JiongBuy50.00K$8.57428.50K
2023-03-31Thomas SteffenBuy50.00K$8.57428.50K
2023-03-31Velden Claus VanderBuy50.00K$8.57428.50K
2023-03-31Donhauser Peter D.O.Buy50.00K$8.57428.50K
2023-03-31Skarpelos AthanasiosBuy50.00K$8.57428.50K
2022-06-27Velden Claus VanderBuy50.00K——
2022-06-27Thomas SteffenBuy50.00K——
2022-06-27Donhauser Peter D.O.Buy50.00K$10.09504.50K
2022-06-27Donhauser Peter D.O.Buy50.00K——
2022-06-27Skarpelos AthanasiosBuy50.00K——
2022-06-27Ma JiongBuy50.00K——
2022-05-25Skarpelos AthanasiosSell50.00K$9.06453.00K
2022-05-25Skarpelos AthanasiosBuy50.00K$9.06453.00K
2021-08-02Ma JiongBuy25.00K$18.11452.75K
2021-08-02Velden Claus VanderBuy25.00K$18.11452.75K
2021-08-02Boenisch SandraBuy40.00K$18.11724.40K
2021-08-02Donhauser Peter D.O.Buy25.00K$18.11452.75K
2021-08-02Thomas SteffenBuy25.00K$18.11452.75K
2021-08-02Skarpelos AthanasiosBuy25.00K$18.11452.75K
2021-08-02MISSLING CHRISTOPHER UBuy500.00K$18.119.05M
2021-06-29MISSLING CHRISTOPHER UBuy51.62K$1.3268.14K
2021-06-29MISSLING CHRISTOPHER USell51.62K$26.001.34M
2021-06-29MISSLING CHRISTOPHER USell51.62K$1.3268.14K
2021-06-29Boenisch SandraBuy35.00K$5.92207.20K
2021-06-29Boenisch SandraBuy106.70K$3.28349.96K
2021-06-29Boenisch SandraBuy25.00K$5.68142.00K
2021-06-29Boenisch SandraSell166.70K$26.534.42M
2021-06-29Boenisch SandraSell35.00K$5.92207.20K
2021-06-29Boenisch SandraSell25.00K$5.68142.00K
2021-06-29Boenisch SandraSell106.70K$3.28349.96K
2021-06-02Ma JiongSell35.00K$13.01455.35K
2021-05-21FAVUS ELLIOTBuy50.00K$2.96148.00K
2021-05-21FAVUS ELLIOTBuy1.50K$6.119.16K
2021-05-21FAVUS ELLIOTBuy1.50K$5.668.49K
2021-05-21FAVUS ELLIOTBuy1.50K$4.907.35K
2021-05-21FAVUS ELLIOTBuy1.50K$5.578.36K
2021-05-21FAVUS ELLIOTBuy1.50K$5.648.46K
2021-05-21FAVUS ELLIOTBuy50.00K$0.9246.00K
2021-05-21FAVUS ELLIOTBuy37.50K$1.2045.00K
2021-05-21FAVUS ELLIOTSell1.50K$5.668.49K
2021-05-21FAVUS ELLIOTSell145.00K$11.701.70M
2021-05-21FAVUS ELLIOTSell50.00K$2.96148.00K
2021-05-21FAVUS ELLIOTSell1.50K$4.907.35K
2021-05-21FAVUS ELLIOTSell1.50K$5.578.36K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 188, holders -11 vs prior quarter. Ownership 42.34%.

HolderSharesChangeChange %Value
BLACKROCK, INC.8.06M446.01K+5.86%20.86M
VANGUARD CAPITAL MANAGEMENT LLC4.05M190.64K+4.93%10.50M
TWO SIGMA INVESTMENTS, LP3.05M-201.35K-6.20%7.89M
GEODE CAPITAL MANAGEMENT, LLC2.41M219.20K+10.02%6.24M
STATE STREET CORP1.92M-2.59M-57.39%4.98M
FEDERATED HERMES, INC.1.07M539.56K+101.37%2.78M
AQR CAPITAL MANAGEMENT LLC963.01K206.22K+27.25%2.49M
VANGUARD PORTFOLIO MANAGEMENT LLC948.63K165.49K+21.13%2.46M
SUMMIT FINANCIAL, LLC909.43K-31.02K-3.30%2.36M
GOLDMAN SACHS GROUP INC890.63K86.20K+10.72%2.31M
MARSHALL WACE, LLP889.52K470.03K+112.05%2.30M
NORTHERN TRUST CORP784.49K59.31K+8.18%2.03M
BARCLAYS PLC754.23K215.95K+40.12%1.95M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC734.79K-21.76K-2.88%1.90M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.734.79K734.79KNew1.90M
BANK OF AMERICA CORP /DE/654.29K-208.85K-24.20%1.69M
VANGUARD FIDUCIARY TRUST CO621.45K-25.72K-3.97%1.61M
UBS GROUP AG620.37K50.42K+8.85%1.61M
GREAT POINT PARTNERS LLC521.30K00.00%1.35M
PRIVATE ADVISOR GROUP, LLC504.00K4.30K+0.86%1.31M
LPL FINANCIAL LLC406.11K-12.53K-2.99%1.05M
STIFEL FINANCIAL CORP332.60K95.79K+40.45%861.43K
CITADEL ADVISORS LLC329.12K269.92K+455.94%852.41K
PVG ASSET MANAGEMENT CORP327.34K-200-0.06%847.82K
SUSQUEHANNA INTERNATIONAL GROUP, LLP319.53K80.03K+33.42%827.58K

Earnings and financials

Anavex Life Sciences Corp. (AVXL) trades at $1.27, with a market cap of $118.19M and a trailing P/E of -4.90. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
0000000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Anavex Life Sciences (AVXL) Financials: Revenue & Earnings

AVXL$1.27-0.04 -2.67%

$118.19M

Market Cap

-4.90

P/E

0.56

Forward P/E

70

Score

Price History